Abstract

Introduction: Aortic stenosis (AS) is the most common primary valve disease in Europe and the United States. The prevalence of severe AS is estimated to be around 1 million by 2025, and survival without valve replacement is about 2-3 years. It is therefore imperative to develop strategies for the early identification and risk stratification of patients with AS. Although valvar calcification is a known intrinsic mechanism leading to AS, the impact of Aortic valve calcium (AVC) progression on the development of AS is unknown

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call